Article Text

Download PDFPDF

  1. S Cahill-Smith,
  2. J M Li
  1. University of Surrey


    Ageing has been recognised to be a major risk factor for the development of cardiovascular disease and growing evidence suggests a role for oxidative stress. NADPH oxidase 2 has been reported to be a major source of reactive oxygen species (ROS) generation in the cardiovascular system, however, the role of this enzyme in age-related metabolic disorders and vascular diseases remains unclear. In this study we used age-matched wild-type (WT) and Nox2-deficient (Nox2−/−) mice on a C57BL/6 background at young (3–4 month) and ageing (20-24 month) to investigate the role of Nox2 in age-related oxidative stress, metabolic disorders and vascular dysfunction. There was an age-related increase in blood pressure in WT mice (126 mmHg for young and 148 mmHg for ageing) (P<0.05); however the blood pressure remained at lower levels in Nox2−/− ageing mice. Compared with young WT mice, WT ageing mice had significantly high levels of fasting serum insulin and this was accompanied with delayed clearance of glucose (P<0.05) indicating insulin resistance. However, no indication of insulin resistance was found in Nox2−/− ageing mice. The endothelial function was examined using aortic rings in an organ bath. Compared to the young controls, there was a significant decrease in the endothelium-dependent relaxation to acetylcholine in WT ageing aortas (Emax 72% for young and 64% for ageing, P<0.05). However, endothelial function was well preserved in Nox2−/− ageing aortas (Emax 83% for young and 80% for ageing. The ROS production was then measured in aortic sections by DHE fluorescence and a significant increase was found in ROS production in WT ageing aortas as compared to WT young controls (P<0.05). However, there was a significantly lower level of ROS production (P<0.05) in both age-matched Nox2−/− aortas. In conclusion, Nox2-derived oxidative stress plays an important role in ageing-associated metabolic disorders and vascular dysfunction, and targeting Nox2 represents a valuable therapeutic strategy to treat these aging-related diseases.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.